Peptides  ›  Semax  ›  Focus & Cognition
Cognitive & Mood

Semax for Focus & Cognition: What the Research Says

Primarily Russian clinical and preclinical research.Updated August 2026

Semax (also known as ACTH 4-10 analog) is a neuropeptide studied for cognition and neuroprotection. This page covers what the published research does — and does not — establish about it in relation to focus, memory and cognition.

What the research covers

Semax is researched for Memory & focus, Neuroprotection — which is why it appears in discussions of focus, memory and cognition.

Research status: Primarily Russian clinical and preclinical research.

How Semax is thought to work

Semax is a synthetic peptide derived from a fragment of ACTH, developed in Russia and studied for cognitive and neuroprotective effects. Research points to influence on BDNF and other neurotrophic factors, and it has been used in regional clinical settings including stroke recovery.

What it does not establish

Evidence is largely region-specific. Not an approved medication in the US/EU.

Nothing on this page is a recommendation to use Semax, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.

Commonly researched alongside

A synthetic peptide studied in Russia for anxiety and cognitive effects.

Other peptides researched for Focus & Cognition

A synthetic peptide studied in Russia for anxiety and cognitive effects.

A short peptide studied for neuroprotection and cognitive effects.

Frequently asked questions

Primarily Russian clinical and preclinical research. Research relevant to this area covers memory & focus, neuroprotection. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.

Primarily Russian clinical and preclinical research.

Evidence is largely region-specific. Not an approved medication in the US/EU. Always speak to a licensed healthcare professional before considering any peptide.

Memory and focus, neuroprotection, and — in regional clinical studies — stroke recovery. Evidence is largely region-specific.

No. It is not an approved medication in the US or EU. Much of the clinical use and research is based in Russia.

Is Semax right for your situation?

Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.

Ask the Advisor — free

This page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.